Abstract
Hemophilia is a rare disease hereditary bleeding disorder which needed continuous treatment and life-long care. Regular prophylaxis treatment (RPT) is recommended as a standard treatment regimen, while intermittent prophylaxis treatment (IPT) and on-demand treatment (ODT) is commonly utilized in reality under resource constrain. In China, approximately 39,000 patients live with hemophilia. However, little is known about patients’ treatment model in real life and related clinical outcomes. The aim of this study was to analyze patient-reported clinical outcomes with three hemophilia treatment regimens in real world in China.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
